Form 4: Cosmos Health Director Acquires 40,000 Shares

Director Anastasios Aslidis acquired 40,000 shares of Cosmos Health common stock through an equity incentive plan.

Summary

• Director Anastasios Aslidis acquired 40,000 shares of common stock on May 19, 2026.
• The shares were acquired at a price of $0.283 per share.
• The transaction was executed under the Issuer's 2024 & 2025 Omnibus Incentive Plan.
• Following this transaction, the director's total beneficial ownership is 100,000 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard director compensation and alignment rather than a significant strategic shift.

Positives

• Director demonstrates alignment with shareholder interests through increased equity ownership.

Negatives

• None noted.

Risks

• None noted.

Future Outlook

Not applicable as this is an insider transaction report.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices intended to align leadership incentives with long-term company performance.

Comparison to Industry Standards

• The use of Omnibus Incentive Plans for director compensation is consistent with standard practices for small-cap healthcare and pharmaceutical companies.

Stakeholder Impact

• Increased alignment between the director and shareholders.

Key Dates

Keywords

Cosmos Health, COSM, Insider Trading, Form 4, Equity Incentive Plan, Director Ownership